A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
Latest Information Update: 11 Jun 2024
At a glance
- Drugs Voclosporin (Primary) ; Mycophenolate; Steroids
- Indications Lupus nephritis
- Focus Registrational; Therapeutic Use
- Acronyms AURORA 1
- Sponsors Aurinia Pharmaceuticals
- 05 Jun 2024 According to Aurinia Pharmaceuticals Inc. media release, data from the study will be presented at the European Alliance of Associations for Rheumatology (EULAR) 2024 taking place in Vienna, Austria June 12-15.
- 05 Jun 2024 Results presented in the Aurinia Pharmaceuticals Media Release.
- 14 May 2024 Results presented in the Aurinia Pharmaceuticals Inc. Media Release.